Who owns Madrigal Pharmaceuticals?
- Ticker: MDGL
- CUSIP Number: 558868105
Tip: Access positions for across all investors
Analyze quarterly positions in Madrigal Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Madrigal Pharmaceuticals stock
Who bought or sold Madrigal Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Henderson Group | 2.6M | $695M | -10% | Mar 2024 |
|
| Baker Bros. Advisors | 2.0M | $526M | 0% | Mar 2024 |
|
| venBio Select Advisor | 1.9M | $437M | 21% | Dec 2023 |
|
| Paulson & Co | 1.8M | $474M | 61% | Mar 2024 |
|
| Vanguard Group | 1.7M | $446M | 6% | Mar 2024 |
|
| BlackRock | 1.2M | $323M | 17% | Mar 2024 |
|
| T. Rowe Price Associates | 803k | $215M | 107% | Mar 2024 |
|
| Susquehanna International | 775k | $207M | 49% | Mar 2024 |
|
| FMR | 714k | $191M | 62% | Mar 2024 |
|
| Perceptive Advisors | 430k | $115M | 184% | Mar 2024 |
|
| Artisan Partners Limited Partnership | 402k | $107M | 35% | Mar 2024 |
|
| Geode Capital Management | 347k | $93M | 17% | Mar 2024 |
|
| Alliancebernstein | 340k | $79M | -6% | Dec 2023 |
|
| Morgan Stanley | 289k | $77M | 68% | Mar 2024 |
|
| Rock Springs Capital Management | 286k | $76M | 46% | Mar 2024 |
|
| Point72 Asset Management | 244k | $65M | 100% | Mar 2024 |
|
| Citadel Advisors | 217k | $58M | 72% | Mar 2024 |
|
| RA Capital Management | 205k | $55M | 0% | Mar 2024 |
|
| Bain Capital Life Sciences Investors | 197k | $53M | 100% | Mar 2024 |
|
| Twin Tree Management | 196k | $52M | 100% | Mar 2024 |
|
| Pictet Asset Management Holding SA | 184k | $48M | 100% | Mar 2024 |
|
| 683 Capital Management | 178k | $48M | 1679% | Mar 2024 |
|
| Armistice Capital | 168k | $45M | -37% | Mar 2024 |
|
| Northern Trust | 131k | $35M | 6% | Mar 2024 |
|
| Tao Capital Management | 131k | $35M | 68% | Mar 2024 |
|
| UBS Group | 125k | $34M | 42% | Mar 2024 |
|
| Charles Schwab Investment Management | 123k | $33M | 2% | Mar 2024 |
|
| Bank of America Corporation | 113k | $30M | -16% | Mar 2024 |
|
| Artal Group | 111k | $30M | 100% | Mar 2024 |
|
| Rheos Capital Works | 110k | $29M | 100% | Mar 2024 |
|
| AlpInvest Partners B.V. | 106k | $28M | -50% | Mar 2024 |
|
| Emerald Advisers | 102k | $27M | 113% | Mar 2024 |
|
| Goldman Sachs Group | 101k | $27M | 7% | Mar 2024 |
|
| American Century Companies | 98k | $26M | 54% | Mar 2024 |
|
| Lord, Abbett & Co | 97k | $26M | 100% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 94k | $25M | 73% | Mar 2024 |
|
| Mirae Asset Global Investments | 92k | $22M | 50% | Mar 2024 |
|
| Ensign Peak Advisors | 92k | $25M | 81% | Mar 2024 |
|
| Cutler | 85k | $23M | -11% | Mar 2024 |
|
| Emerald Mutual Fund Advisers, Trust | 76k | $20M | 93% | Mar 2024 |
|
| EcoR1 Capital | 75k | $20M | 100% | Mar 2024 |
|
| Nuveen Asset Management | 71k | $19M | 79% | Mar 2024 |
|
| D. E. Shaw & Co | 68k | $18M | 36% | Mar 2024 |
|
| Wolverine Trading | 65k | $17M | 77% | Mar 2024 |
|
| Gts Securities | 65k | $17M | 8% | Mar 2024 |
|
| Fred Alger Management | 65k | $17M | 257% | Mar 2024 |
|
| MPM Oncology Impact Management | 61k | $16M | 50% | Mar 2024 |
|
| Bank of New York Mellon | 58k | $16M | -7% | Mar 2024 |
|
| Jpmorgan Chase & Co | 55k | $15M | -7% | Mar 2024 |
|
| Tri Locum Partners | 53k | $14M | 109% | Mar 2024 |
|
| Ikarian Capital | 51k | $14M | 100% | Mar 2024 |
|
| Sio Capital Management | 51k | $14M | 100% | Mar 2024 |
|
| TD Asset Management | 50k | $13M | 224% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 47k | $12M | -22% | Mar 2024 |
|
| Group One Trading | 43k | $12M | -43% | Mar 2024 |
|
| Propel Bio Management | 43k | $12M | 43% | Mar 2024 |
|
| T. Rowe Price Investment Management | 43k | $12M | 100% | Mar 2024 |
|
| Rokos Capital Management | 38k | $10M | 100% | Mar 2024 |
|
| Rhenman & Partners Asset Management AB | 37k | $9.7M | 100% | Mar 2024 |
|
| Rafferty Asset Management | 36k | $9.6M | -21% | Mar 2024 |
|
| Skandinaviska Enskilda Banken AB | 35k | $9.4M | 566% | Mar 2024 |
|
| Barclays | 34k | $9.1M | -11% | Mar 2024 |
|
| Arrowpoint Asset Management | 34k | $9.1M | 100% | Mar 2024 |
|
| Rockefeller Capital Management | 33k | $7.6M | 82% | Dec 2023 |
|
| Citigroup | 33k | $8.8M | 25% | Mar 2024 |
|
| Hennion & Walsh Asset Management | 32k | $8.6M | 20% | Mar 2024 |
|
| Atlantic Trust | 30k | $7.7M | 100% | Mar 2024 |
|
| Squarepoint Ops | 30k | $8.0M | 100% | Mar 2024 |
|
| LMR Partners | 26k | $7.0M | -64% | Mar 2024 |
|
| Jane Street | 25k | $6.7M | -88% | Mar 2024 |
|
| Swiss National Bank | 23k | $6.2M | 9% | Mar 2024 |
|
| Simplify Asset Management | 23k | $6.2M | 63% | Mar 2024 |
|
| New York State Common Retirement Fund | 22k | $6.0M | 22% | Mar 2024 |
|
| Handelsbanken Fonder AB | 22k | $6.0M | 576% | Mar 2024 |
|
| Rhumbline Advisers | 21k | $5.6M | 3% | Mar 2024 |
|
| Raymond James & Associates | 20k | $5.4M | 3% | Mar 2024 |
|
| CalPERS | 20k | $5.4M | 0% | Mar 2024 |
|
| Woodline Partners | 20k | $5.3M | 100% | Mar 2024 |
|
| Wayne Hummer Investments | 19k | $5.1M | -6% | Mar 2024 |
|
| Sofinnova Ventures | 19k | $5.1M | 100% | Mar 2024 |
|
| Caption Management | 19k | $5.0M | 100% | Mar 2024 |
|
| Candriam Luxembourg S.C.A. | 18k | $4.8M | -33% | Mar 2024 |
|
| Ing Investment Management | 18k | $4.7M | 73% | Mar 2024 |
|
| Hsbc Holdings | 17k | $3.9M | 19% | Dec 2023 |
|
| Wells Fargo & Company | 17k | $4.5M | -76% | Mar 2024 |
|
| Boothbay Fund Management | 15k | $4.0M | 100% | Mar 2024 |
|
| Ubs Global Asset Management Americas | 14k | $3.8M | 0% | Mar 2024 |
|
| Journey Strategic Wealth | 13k | $3.6M | 0% | Mar 2024 |
|
| Blue Owl Capital Holdings | 13k | $3.6M | 100% | Mar 2024 |
|
| Assenagon Asset Management | 13k | $3.5M | -32% | Mar 2024 |
|
| Capital Fund Management | 13k | $3.3M | 100% | Mar 2024 |
|
| Legal & General Group | 12k | $3.3M | 1% | Mar 2024 |
|
| California State Teachers Retirement System | 12k | $3.2M | 2% | Mar 2024 |
|
| State of New Jersey Common Pension Fund D | 12k | $3.2M | -9% | Mar 2024 |
|
| Mutual Of America Capital Management | 12k | $3.2M | -8% | Mar 2024 |
|
| Credit Suisse | 12k | $3.1M | 10% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 11k | $3.0M | -50% | Mar 2024 |
|
| Cubist Systematic Strategies | 11k | $3.0M | 159% | Mar 2024 |
|
| Newbridge Financial Services Group | 11k | $2.9M | 100% | Mar 2024 |
|
| Sei Investments | 11k | $2.8M | 4% | Mar 2024 |
|
| Adage Capital Partners GP | 10k | $2.7M | 100% | Mar 2024 |
|
| AMI Asset Management Corporation | 9.6k | $2.6M | 102% | Mar 2024 |
|
| CastleArk Management | 9.2k | $2.5M | 100% | Mar 2024 |
|
| State of Wisconsin Investment Board | 8.6k | $2.3M | -3% | Mar 2024 |
|
| DekaBank Deutsche Girozentrale | 8.0k | $2.1M | 0% | Mar 2024 |
|
| Exome Asset Management | 7.9k | $2.1M | -40% | Mar 2024 |
|
| MetLife Investment Advisors | 7.8k | $1.8M | 8% | Dec 2023 |
|
| American International | 7.4k | $1.7M | 8% | Dec 2023 |
|
| Tudor Investment Corporation | 6.7k | $1.8M | 100% | Mar 2024 |
|
| Martingale Asset Management | 6.6k | $1.5M | 11% | Dec 2023 |
|
| Millennium Management | 6.6k | $1.7M | -45% | Mar 2024 |
|
| ProFund Advisors | 5.8k | $1.5M | -25% | Mar 2024 |
|
| NEOS Investment Management | 5.6k | $1.5M | 100% | Mar 2024 |
|
| Russell Investments | 5.5k | $1.5M | 100% | Mar 2024 |
|
| Shikiar Asset Management | 5.4k | $1.4M | 8% | Mar 2024 |
|
| AQR Capital Management | 5.3k | $1.4M | -13% | Mar 2024 |
|
| Wellington Management Company | 5.2k | $1.2M | 100% | Dec 2023 |
|
| Knights of Columbus Asset Advisors | 5.2k | $1.4M | -41% | Mar 2024 |
|
| Moody Aldrich Partners | 5.1k | $1.4M | -44% | Mar 2024 |
|
| Pentwater Capital Management | 5.0k | $1.3M | 100% | Mar 2024 |
|
| Envestnet Asset Management | 4.8k | $1.3M | 14% | Mar 2024 |
|
| Virtu Financial | 4.1k | $940k | 100% | Dec 2023 |
|
| ProShare Advisors | 4.1k | $1.1M | 36% | Mar 2024 |
|
| Principal Financial Group | 4.0k | $1.1M | 3% | Mar 2024 |
|
| Verition Fund Management | 4.0k | $1.1M | 0% | Mar 2024 |
|
| China Universal Asset Management | 3.8k | $1.0M | 66% | Mar 2024 |
|
| Capital Impact Advisors | 3.7k | $995k | -25% | Mar 2024 |
|
| Calamos Advisors | 3.6k | $965k | 100% | Mar 2024 |
|
| Kestra Advisory Services | 3.6k | $834k | 0% | Dec 2023 |
|
| Florida State Board of Administration | 3.6k | $867k | -8% | Mar 2024 |
|
| First National Trust Company | 3.5k | $946k | -20% | Mar 2024 |
|
| HealthInvest Partners AB | 3.5k | $945k | 40% | Mar 2024 |
|
| AtonRa Partners | 3.4k | $794k | -11% | Dec 2023 |
|
| LPL Financial | 3.4k | $916k | 100% | Mar 2024 |
|
| Guggenheim Capital, LLC Managers | 3.4k | $792k | 9% | Dec 2023 |
|
| Farallon Capital Management | 3.3k | $886k | 100% | Mar 2024 |
|
| Dana Investment Advisors | 3.3k | $875k | 3% | Mar 2024 |
|
| Arizona State Retirement System | 3.3k | $869k | 7% | Mar 2024 |
|
| Verity Asset Management | 2.7k | $622k | 0% | Dec 2023 |
|
| Creative Planning | 2.7k | $715k | 44% | Mar 2024 |
|
| Teacher Retirement System Of Texas | 2.6k | $704k | 7% | Mar 2024 |
|
| Mariner Wealth Advisors | 2.6k | $703k | 109% | Mar 2024 |
|
| HighVista Strategies | 2.5k | $677k | -17% | Mar 2024 |
|
| Royal Bank of Canada | 2.5k | $674k | -63% | Mar 2024 |
|
| XR Securities | 2.4k | $641k | 0% | Mar 2024 |
|
| Parallax Volatility Advisers | 2.4k | $641k | -52% | Mar 2024 |
|
| Cambridge Investment Research Advisors | 2.4k | $637k | -61% | Mar 2024 |
|
| Susquehanna Fundamental Investments | 2.2k | $584k | 100% | Mar 2024 |
|
| Seaport Global Advisors | 2.1k | $570k | -33% | Mar 2024 |
|
| Victory Capital Management | 2.1k | $568k | 11% | Mar 2024 |
|
| Walleye Trading | 2.1k | $561k | -87% | Mar 2024 |
|
| E Fund Management | 1.7k | $453k | -26% | Mar 2024 |
|
| Ameriprise Financial | 1.6k | $431k | -68% | Mar 2024 |
|
| Public Employees' Retirement Association of Colorado | 1.4k | $383k | -94% | Mar 2024 |
|
| Leucadia National Corporation | 1.0k | $267k | -84% | Mar 2024 |
|
| Sumitomo Mitsui Trust Holdings | 839.00 | $224k | -65% | Mar 2024 |
|
| Simplex Trading | 593.00 | $158k | -85% | Mar 2024 |
|
| Amalgamated Bank | 505.00 | $135k | -76% | Mar 2024 |
|
| Groupama Asset Managment | 215.00 | $3.0M | -98% | Mar 2024 |
|
Who sold out of Madrigal Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Norges Bank Investment Management | Dec 2023 | 146k | $34M |
| Frazier Life Sciences Management | Dec 2023 | 69k | $16M |
| L1 Capital Pty | Dec 2023 | 50k | $12M |
| Marshall Wace | Dec 2023 | 33k | $7.7M |
| Sphera Funds Management | Dec 2023 | 28k | $6.4M |
| Rosalind Advisors | Dec 2023 | 25k | $5.8M |
| Weiss Multi-strategy Advisers | Dec 2023 | 18k | $4.2M |
| CenterBook Partners | Sep 2023 | 18k | $2.6M |
| Osterweis Capital Management | Dec 2023 | 15k | $3.5M |
| Schonfeld Strategic Advisors | Dec 2023 | 13k | $2.9M |
| Polar Securities | Dec 2023 | 9.9k | $2.3M |
| ExodusPoint Capital Management | Sep 2023 | 8.2k | $1.2M |
| Bank Of Montreal | Dec 2023 | 7.8k | $1.9M |
| Campbell & Co. Investment Adviser | Sep 2023 | 6.6k | $960k |
| Nebula Research & Development | Sep 2023 | 6.6k | $957k |
| Hrt Financial | Dec 2023 | 3.7k | $859k |
| Fox Run Management | Sep 2023 | 2.8k | $414k |
| Jump Financial | Sep 2023 | 2.4k | $345k |
| Brevan Howard Capital Management | Dec 2023 | 2.3k | $531k |